{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/VERA/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T07:54:51.087Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":4629,"canonical_name":"Vera Therapeutics, Inc.","cik":"0001831828","uei":null,"lei":null,"duns":null,"ticker":"VERA"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":34},"count":34,"timeline":[{"ts":"2026-09-17","kind":"sec.filing","form_type":"4","title":"4 — Vera Therapeutics, Inc. — 2026-09-17","url_slug":"/sec/cik-0001831828/4/0001859453-26-000015","accession_number":"0001859453-26-000015","importance":30},{"ts":"2026-09-15","kind":"sec.filing","form_type":"8-K","title":"8-K — Vera Therapeutics, Inc. — 2026-09-15","url_slug":"/sec/cik-0001831828/8-k/0001193125-26-391280","accession_number":"0001193125-26-391280","importance":35},{"ts":"2026-09-14","kind":"sec.filing","form_type":"4","title":"4 — Vera Therapeutics, Inc. — 2026-09-14","url_slug":"/sec/cik-0001831828/4/0001861684-26-000006","accession_number":"0001861684-26-000006","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"4","title":"4 — Vera Therapeutics, Inc. — 2026-09-04","url_slug":"/sec/cik-0001831828/4/0001859453-26-000014","accession_number":"0001859453-26-000014","importance":30},{"ts":"2026-09-02","kind":"sec.filing","form_type":"144","title":"144 — Vera Therapeutics, Inc. — 2026-09-02","url_slug":"/sec/cik-0001831828/144/0001950047-26-009028","accession_number":"0001950047-26-009028","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Vera Therapeutics, Inc. — 2026-08-14","url_slug":"/sec/cik-0001831828/schedule-13g-a/0001907884-26-000015","accession_number":"0001907884-26-000015","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"4/A","title":"4/A — Vera Therapeutics, Inc. — 2026-08-12","url_slug":"/sec/cik-0001831828/4-a/0001859453-26-000011","accession_number":"0001859453-26-000011","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"4/A","title":"4/A — Vera Therapeutics, Inc. — 2026-08-12","url_slug":"/sec/cik-0001831828/4-a/0001859453-26-000012","accession_number":"0001859453-26-000012","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"4/A","title":"4/A — Vera Therapeutics, Inc. — 2026-08-12","url_slug":"/sec/cik-0001831828/4-a/0001859453-26-000013","accession_number":"0001859453-26-000013","importance":30},{"ts":"2026-08-10","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Vera Therapeutics, Inc. — 2026-08-10","url_slug":"/sec/cik-0001831828/10-q/0001193125-26-342380","accession_number":"0001193125-26-342380","importance":45},{"ts":"2026-08-10","kind":"sec.filing","form_type":"8-K","title":"8-K — Vera Therapeutics, Inc. — 2026-08-10","url_slug":"/sec/cik-0001831828/8-k/0001193125-26-342335","accession_number":"0001193125-26-342335","importance":35},{"ts":"2026-08-07","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Vera Therapeutics, Inc. — 2026-08-07","url_slug":"/sec/cik-0001831828/schedule-13g/0000093751-26-000554","accession_number":"0000093751-26-000554","importance":55},{"ts":"2026-08-05","kind":"sec.filing","form_type":"3","title":"3 — Vera Therapeutics, Inc. — 2026-08-05","url_slug":"/sec/cik-0001831828/3/0002145711-26-000001","accession_number":"0002145711-26-000001","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — Vera Therapeutics, Inc. — 2026-08-05","url_slug":"/sec/cik-0001831828/4/0002145711-26-000002","accession_number":"0002145711-26-000002","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Vera Therapeutics, Inc. — 2026-07-30","url_slug":"/sec/cik-0001831828/schedule-13g-a/0002012383-26-003123","accession_number":"0002012383-26-003123","importance":30},{"ts":"2026-07-09","kind":"sec.filing","form_type":"8-K","title":"8-K — Vera Therapeutics, Inc. — 2026-07-09","url_slug":"/sec/cik-0001831828/8-k/0001193125-26-299165","accession_number":"0001193125-26-299165","importance":35},{"ts":"2026-07-09","kind":"sec.filing","form_type":"4","title":"4 — Vera Therapeutics, Inc. — 2026-07-09","url_slug":"/sec/cik-0001831828/4/0001859453-26-000010","accession_number":"0001859453-26-000010","importance":30},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Fordyce Marshall","title":"PRESIDENT AND CEO","shares":32550,"price_per_share":42.0736,"usd_value":1369496,"security_title":"Class A Common Stock","importance":36.36949568},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Fordyce Marshall","title":"PRESIDENT AND CEO","shares":10500,"price_per_share":42.8578,"usd_value":450007,"security_title":"Class A Common Stock","importance":35.4500069},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Fordyce Marshall","title":"PRESIDENT AND CEO","shares":2200,"price_per_share":43.5947,"usd_value":95908,"security_title":"Class A Common Stock","importance":35.09590834},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Fordyce Marshall","title":"PRESIDENT AND CEO","shares":1000,"price_per_share":40.7762,"usd_value":40776,"security_title":"Class A Common Stock","importance":35.0407762},{"ts":"2026-07-07","kind":"sec.filing","form_type":"8-K","title":"8-K — Vera Therapeutics, Inc. — 2026-07-07","url_slug":"/sec/cik-0001831828/8-k/0001193125-26-297211","accession_number":"0001193125-26-297211","importance":35},{"ts":"2026-06-24","kind":"sec.filing","form_type":"4","title":"4 — Vera Therapeutics, Inc. — 2026-06-24","url_slug":"/sec/cik-0001831828/4/0001859453-26-000008","accession_number":"0001859453-26-000008","importance":30},{"ts":"2026-06-23","kind":"sec.form144","reporter":"MARSHALL FORDYCE","title":"Director, Officer","shares":74000,"usd_value":2843820,"security_title":"Common","approx_sale_date":"2026-06-23","accession_number":"0001950047-26-006433","importance":40.568764},{"ts":"2026-06-23","kind":"sec.insider.s","reporter":"Fordyce Marshall","title":"PRESIDENT AND CEO","shares":18412,"price_per_share":37.9311,"usd_value":698387,"security_title":"Class A Common Stock","importance":35.6983874132},{"ts":"2026-06-23","kind":"sec.insider.s","reporter":"Fordyce Marshall","title":"PRESIDENT AND CEO","shares":88,"price_per_share":38.43,"usd_value":3382,"security_title":"Class A Common Stock","importance":35.00338184},{"ts":"2026-06-23","kind":"sec.filing","form_type":"144","title":"144 — Vera Therapeutics, Inc. — 2026-06-23","url_slug":"/sec/cik-0001831828/144/0001950047-26-006433","accession_number":"0001950047-26-006433","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"8-K","title":"8-K — Vera Therapeutics, Inc. — 2026-06-02","url_slug":"/sec/cik-0001831828/8-k/0001193125-26-252475","accession_number":"0001193125-26-252475","importance":35},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Vera Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001831828/schedule-13g-a/0000080255-26-000426","accession_number":"0000080255-26-000426","importance":30},{"ts":"2026-05-13","kind":"sec.filing","form_type":"4","title":"4 — Vera Therapeutics, Inc. — 2026-05-13","url_slug":"/sec/cik-0001831828/4/0001859453-26-000007","accession_number":"0001859453-26-000007","importance":30},{"ts":"2026-05-12","kind":"sec.form144","reporter":"MARSHALL FORDYCE","title":"Director, Officer","shares":18500,"usd_value":677285,"security_title":"Common","approx_sale_date":"2026-05-12","accession_number":"0001950047-26-004408","importance":40.135457},{"ts":"2026-05-12","kind":"sec.insider.s","reporter":"Fordyce Marshall","title":"PRESIDENT AND CEO","shares":14219,"price_per_share":36.6396,"usd_value":520978,"security_title":"Class A Common Stock","importance":35.5209784724},{"ts":"2026-05-12","kind":"sec.insider.s","reporter":"Fordyce Marshall","title":"PRESIDENT AND CEO","shares":4281,"price_per_share":37.0868,"usd_value":158769,"security_title":"Class A Common Stock","importance":35.1587685908},{"ts":"2026-05-12","kind":"sec.filing","form_type":"144","title":"144 — Vera Therapeutics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001831828/144/0001950047-26-004408","accession_number":"0001950047-26-004408","importance":30}]}